Phase 1 Pediatric HIV Infection Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin

Pediatric HIV InfectionTuberculosis Infection

Brigham and Women's Hospital20 enrolled1 locationNCT05069688

Recruiting

Phase 1

Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention

Pediatric HIV InfectionLatent Tuberculosis

Brigham and Women's Hospital25 enrolled1 locationNCT06281834